An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.
It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...
The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.
Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the ...
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
ScienceAlert on MSN5d
Anti-Amyloid Drug May Delay Alzheimer's Symptoms in Those at Risk, Clinical Trial FindsA method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...
Analysts were happy with batoclimab’s performance in the chronic autoimmune disorder, but Immunovant said it will continue to ...
Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback